Pipeline drug offers promise in treatment of platinum-resistant ovarian cancer: GlobalData
ImmunoGen announced that the first patient was dosed in its pivotal Phase III study that investigates mirvetuximab soravtansine as…
Author
Bladder cancer market size to more than triple to over $1.1 billion by 2025
The growth will be driven by the increased incorporation of immunotherapies into treatment algorithms, the launch of new…
Driving Innovation The NDDS Way
The need for a multidisciplinary approach to deliver greater therapeutic results has opened new avenues for growth in the novel…
Generating value in generics
Utkarsh Palnitkar, Partner and Head, Infrastructure, Government and Healthcare, Life Sciences, KPMG in India, gives an insight on…
IPM valued at Rs 9,225 crores in March 2017
Domestic companies continued to dominate the market with a 78 per cent share in March 2017
Express Pharma (Vol. 12, No. 13) May 1-15, 2017
India's Foremost Pharma & Biotech Magazine
The push towards pure generics: Impact on pharma marketing
Mala Raj, Senior Pharma Marketing and Medical Consultant at PMS Services contemplates the consequences of the generic push on some…
Veeva releases survey on digitalisation in Indian pharma
Reports reveals 66 per cent of respondents believe digital will become core to company strategy over the next three years
Health ministry to launch pneumonia vaccine on May 13
In the first phase, the vaccine will be administered under routine immunisation programme in parts of Bihar, Uttar Pradesh and…
Aptar Pharma partners with Kali Care
The partnership aims to develop real-time medication management technology